| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 13 | 2023 | 799 | 2.570 |
Why?
|
| Hypertension | 27 | 2021 | 1318 | 2.330 |
Why?
|
| Antihypertensive Agents | 13 | 2021 | 411 | 1.690 |
Why?
|
| Primary Health Care | 15 | 2017 | 771 | 1.640 |
Why?
|
| Cognition Disorders | 6 | 2019 | 553 | 1.150 |
Why?
|
| Cognition | 8 | 2024 | 721 | 1.020 |
Why?
|
| Neuropsychological Tests | 9 | 2024 | 924 | 0.830 |
Why?
|
| Cognitive Dysfunction | 5 | 2024 | 238 | 0.810 |
Why?
|
| Computer Communication Networks | 1 | 2022 | 15 | 0.770 |
Why?
|
| International Cooperation | 1 | 2022 | 157 | 0.720 |
Why?
|
| Blood Pressure | 8 | 2021 | 1351 | 0.710 |
Why?
|
| Medication Adherence | 4 | 2021 | 396 | 0.630 |
Why?
|
| Disease Progression | 4 | 2021 | 2047 | 0.620 |
Why?
|
| Caregivers | 1 | 2023 | 559 | 0.600 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 1108 | 0.580 |
Why?
|
| Aged | 33 | 2024 | 19700 | 0.540 |
Why?
|
| Patient Compliance | 5 | 2014 | 471 | 0.490 |
Why?
|
| Dementia | 4 | 2022 | 452 | 0.490 |
Why?
|
| Drug Resistance | 2 | 2014 | 257 | 0.460 |
Why?
|
| Vestibular Function Tests | 1 | 2014 | 34 | 0.450 |
Why?
|
| Office Visits | 1 | 2014 | 77 | 0.440 |
Why?
|
| Middle Aged | 41 | 2024 | 26712 | 0.430 |
Why?
|
| Community Networks | 1 | 2013 | 33 | 0.430 |
Why?
|
| Patient Education as Topic | 4 | 2016 | 437 | 0.430 |
Why?
|
| Vestibular Diseases | 1 | 2014 | 67 | 0.420 |
Why?
|
| Cyclobutanes | 1 | 2013 | 6 | 0.420 |
Why?
|
| Mental Recall | 1 | 2014 | 143 | 0.410 |
Why?
|
| Appetite Depressants | 1 | 2013 | 22 | 0.410 |
Why?
|
| Health Services Research | 2 | 2013 | 187 | 0.400 |
Why?
|
| Ceramides | 1 | 2012 | 38 | 0.390 |
Why?
|
| Humans | 72 | 2024 | 124592 | 0.390 |
Why?
|
| Delivery of Health Care | 3 | 2016 | 607 | 0.380 |
Why?
|
| Male | 54 | 2024 | 61194 | 0.370 |
Why?
|
| Weight Loss | 2 | 2013 | 481 | 0.360 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 475 | 0.340 |
Why?
|
| Female | 52 | 2024 | 66483 | 0.340 |
Why?
|
| Aged, 80 and over | 15 | 2024 | 6533 | 0.330 |
Why?
|
| Vitamin E | 1 | 2009 | 67 | 0.330 |
Why?
|
| Electronic Health Records | 3 | 2016 | 723 | 0.310 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2022 | 11 | 0.310 |
Why?
|
| Elder Abuse | 4 | 2002 | 24 | 0.310 |
Why?
|
| Education | 2 | 2006 | 109 | 0.310 |
Why?
|
| Vaccination | 4 | 2017 | 954 | 0.300 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 275 | 0.300 |
Why?
|
| Adult | 32 | 2018 | 29435 | 0.300 |
Why?
|
| Texas | 16 | 2016 | 3583 | 0.300 |
Why?
|
| Insulin | 2 | 2013 | 1202 | 0.290 |
Why?
|
| Cohort Studies | 5 | 2024 | 4795 | 0.290 |
Why?
|
| Antioxidants | 1 | 2009 | 335 | 0.280 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 1944 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2006 | 1269 | 0.270 |
Why?
|
| Intelligence Tests | 1 | 2006 | 57 | 0.260 |
Why?
|
| Physicians | 2 | 2011 | 581 | 0.260 |
Why?
|
| Immunization Programs | 2 | 2017 | 63 | 0.260 |
Why?
|
| Intelligence | 1 | 2006 | 98 | 0.250 |
Why?
|
| Patient Participation | 1 | 2007 | 221 | 0.240 |
Why?
|
| Obesity | 4 | 2013 | 2262 | 0.240 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 293 | 0.230 |
Why?
|
| Amnesia | 1 | 2024 | 20 | 0.220 |
Why?
|
| Parietal Lobe | 1 | 2024 | 47 | 0.220 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 662 | 0.220 |
Why?
|
| Markov Chains | 1 | 2023 | 84 | 0.210 |
Why?
|
| Health Promotion | 2 | 2016 | 389 | 0.210 |
Why?
|
| Chest Pain | 1 | 2004 | 126 | 0.200 |
Why?
|
| Mood Disorders | 1 | 2004 | 122 | 0.200 |
Why?
|
| Exercise Test | 1 | 2004 | 252 | 0.200 |
Why?
|
| Cohort Effect | 2 | 2019 | 5 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2011 | 1179 | 0.200 |
Why?
|
| Biomarkers | 4 | 2024 | 3062 | 0.200 |
Why?
|
| Life Style | 5 | 2023 | 406 | 0.190 |
Why?
|
| Observational Studies as Topic | 1 | 2022 | 87 | 0.190 |
Why?
|
| Mortality | 1 | 2003 | 238 | 0.180 |
Why?
|
| Self Efficacy | 2 | 2013 | 195 | 0.180 |
Why?
|
| Physician's Role | 1 | 2003 | 164 | 0.180 |
Why?
|
| Blood Pressure Determination | 4 | 2011 | 106 | 0.180 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1322 | 0.180 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 38 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 1267 | 0.180 |
Why?
|
| Risk Factors | 15 | 2014 | 10265 | 0.170 |
Why?
|
| Influenza, Human | 2 | 2017 | 657 | 0.170 |
Why?
|
| Cerebellum | 1 | 2024 | 413 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2007 | 1544 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3554 | 0.160 |
Why?
|
| Regression Analysis | 5 | 2016 | 778 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 2153 | 0.160 |
Why?
|
| Hyperlipidemias | 1 | 2001 | 175 | 0.160 |
Why?
|
| Health Surveys | 3 | 2013 | 239 | 0.160 |
Why?
|
| Health Behavior | 3 | 2012 | 381 | 0.150 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 272 | 0.150 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2018 | 71 | 0.150 |
Why?
|
| Mass Screening | 3 | 2014 | 782 | 0.150 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 3 | 2013 | 54 | 0.150 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 429 | 0.150 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1999 | 160 | 0.140 |
Why?
|
| Network Meta-Analysis | 1 | 2017 | 27 | 0.140 |
Why?
|
| Anxiety | 1 | 2023 | 941 | 0.140 |
Why?
|
| Diphtheria-Tetanus Vaccine | 1 | 2016 | 3 | 0.130 |
Why?
|
| United States | 10 | 2021 | 10887 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2000 | 634 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2016 | 728 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 771 | 0.130 |
Why?
|
| Linear Models | 3 | 2011 | 671 | 0.130 |
Why?
|
| Telephone | 1 | 1996 | 109 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 2 | 2007 | 227 | 0.130 |
Why?
|
| Brain | 2 | 2024 | 2983 | 0.130 |
Why?
|
| Immunization | 1 | 2017 | 307 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 112 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2014 | 1184 | 0.120 |
Why?
|
| Logistic Models | 5 | 2004 | 1805 | 0.120 |
Why?
|
| Pneumococcal Vaccines | 1 | 2016 | 169 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 368 | 0.120 |
Why?
|
| New York | 1 | 2015 | 69 | 0.120 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 5145 | 0.120 |
Why?
|
| Dizziness | 1 | 2014 | 27 | 0.110 |
Why?
|
| Minority Groups | 3 | 1993 | 247 | 0.110 |
Why?
|
| Prevalence | 6 | 2004 | 2445 | 0.110 |
Why?
|
| Activities of Daily Living | 3 | 2022 | 401 | 0.110 |
Why?
|
| Education, Medical | 2 | 2003 | 287 | 0.110 |
Why?
|
| White Coat Hypertension | 1 | 2013 | 10 | 0.110 |
Why?
|
| Physical Examination | 1 | 2014 | 160 | 0.110 |
Why?
|
| Education, Premedical | 2 | 1991 | 2 | 0.110 |
Why?
|
| Alcoholics Anonymous | 1 | 2013 | 3 | 0.110 |
Why?
|
| Temperance | 1 | 2013 | 15 | 0.110 |
Why?
|
| Diabetes Mellitus | 3 | 2013 | 871 | 0.110 |
Why?
|
| Self-Help Groups | 1 | 2013 | 16 | 0.110 |
Why?
|
| Postural Balance | 1 | 2014 | 125 | 0.100 |
Why?
|
| Religion and Medicine | 1 | 2013 | 25 | 0.100 |
Why?
|
| Health Literacy | 1 | 2014 | 80 | 0.100 |
Why?
|
| Motivation | 3 | 2016 | 315 | 0.100 |
Why?
|
| Biostatistics | 1 | 2012 | 11 | 0.100 |
Why?
|
| Spirituality | 1 | 2013 | 47 | 0.100 |
Why?
|
| Patient Selection | 1 | 1996 | 693 | 0.100 |
Why?
|
| Systole | 3 | 2011 | 198 | 0.100 |
Why?
|
| Smoking Cessation | 2 | 2012 | 198 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 218 | 0.100 |
Why?
|
| Young Adult | 3 | 2018 | 9012 | 0.100 |
Why?
|
| Referral and Consultation | 2 | 2014 | 542 | 0.100 |
Why?
|
| Exercise | 4 | 2023 | 813 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2016 | 478 | 0.090 |
Why?
|
| Internal Medicine | 3 | 2016 | 150 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 818 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2017 | 639 | 0.090 |
Why?
|
| Sphingomyelins | 1 | 2011 | 15 | 0.090 |
Why?
|
| Epilepsy | 1 | 2018 | 871 | 0.090 |
Why?
|
| Uncertainty | 1 | 2011 | 98 | 0.090 |
Why?
|
| Self Report | 1 | 2014 | 512 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 224 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2011 | 1014 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2014 | 538 | 0.090 |
Why?
|
| Alcoholism | 1 | 2013 | 232 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2013 | 3421 | 0.090 |
Why?
|
| Emigration and Immigration | 2 | 2001 | 81 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 189 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2007 | 841 | 0.080 |
Why?
|
| Surveys and Questionnaires | 7 | 2018 | 3693 | 0.080 |
Why?
|
| Body Mass Index | 5 | 2007 | 1561 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2009 | 1495 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 453 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 811 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2022 | 16312 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2013 | 3280 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2009 | 471 | 0.070 |
Why?
|
| Survival | 1 | 2006 | 19 | 0.070 |
Why?
|
| Pennsylvania | 2 | 2016 | 53 | 0.070 |
Why?
|
| Community Health Centers | 3 | 2003 | 39 | 0.070 |
Why?
|
| Relief Work | 1 | 2006 | 31 | 0.070 |
Why?
|
| Anthropometry | 2 | 2004 | 199 | 0.070 |
Why?
|
| Diuretics | 2 | 2013 | 171 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2021 | 6135 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2003 | 1350 | 0.060 |
Why?
|
| Geriatrics | 2 | 2006 | 73 | 0.060 |
Why?
|
| Counseling | 1 | 2007 | 216 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2014 | 12324 | 0.060 |
Why?
|
| Disasters | 1 | 2006 | 102 | 0.060 |
Why?
|
| Motor Activity | 2 | 2007 | 522 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 45 | 0.060 |
Why?
|
| Chi-Square Distribution | 4 | 2011 | 587 | 0.060 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 177 | 0.060 |
Why?
|
| Reaction Time | 1 | 2004 | 175 | 0.060 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 112 | 0.050 |
Why?
|
| Visual Perception | 1 | 2004 | 124 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 182 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 804 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2004 | 140 | 0.050 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2003 | 72 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 211 | 0.050 |
Why?
|
| Specialization | 1 | 2003 | 75 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 299 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2004 | 866 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2003 | 77 | 0.050 |
Why?
|
| tau Proteins | 1 | 2024 | 206 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2002 | 3153 | 0.050 |
Why?
|
| Medicine | 1 | 2003 | 97 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2001 | 1138 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 3443 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2024 | 270 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 344 | 0.050 |
Why?
|
| Family Practice | 2 | 2016 | 91 | 0.050 |
Why?
|
| Neuroimaging | 1 | 2024 | 335 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 440 | 0.050 |
Why?
|
| Program Evaluation | 3 | 2016 | 442 | 0.050 |
Why?
|
| Geriatric Assessment | 2 | 2000 | 173 | 0.050 |
Why?
|
| Prejudice | 1 | 2001 | 38 | 0.050 |
Why?
|
| Lipids | 1 | 2004 | 513 | 0.050 |
Why?
|
| Awareness | 1 | 2001 | 79 | 0.050 |
Why?
|
| Syndrome | 1 | 2004 | 1118 | 0.050 |
Why?
|
| Learning | 1 | 2004 | 360 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2004 | 338 | 0.040 |
Why?
|
| Sampling Studies | 2 | 2001 | 77 | 0.040 |
Why?
|
| Incidence | 2 | 2001 | 3138 | 0.040 |
Why?
|
| Cause of Death | 1 | 2003 | 473 | 0.040 |
Why?
|
| Acute Disease | 1 | 2004 | 1109 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2001 | 138 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2001 | 122 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 1428 | 0.040 |
Why?
|
| Glycogen | 1 | 1999 | 63 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2001 | 293 | 0.040 |
Why?
|
| Postprandial Period | 1 | 1999 | 77 | 0.040 |
Why?
|
| American Heart Association | 1 | 2021 | 321 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 1162 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 420 | 0.040 |
Why?
|
| Urban Population | 2 | 1998 | 225 | 0.040 |
Why?
|
| Social Work | 1 | 1999 | 20 | 0.040 |
Why?
|
| Smoking | 1 | 2004 | 1045 | 0.040 |
Why?
|
| Hyperglycemia | 2 | 1999 | 222 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2000 | 223 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2000 | 243 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2012 | 372 | 0.040 |
Why?
|
| Triglycerides | 1 | 2001 | 574 | 0.040 |
Why?
|
| Cholesterol | 1 | 2001 | 536 | 0.040 |
Why?
|
| Social Support | 2 | 2012 | 329 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 606 | 0.040 |
Why?
|
| Age of Onset | 2 | 2011 | 586 | 0.030 |
Why?
|
| Hippocampus | 1 | 2022 | 821 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 1996 | 49 | 0.030 |
Why?
|
| Vaccines, Conjugate | 1 | 2016 | 78 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 1181 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 240 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1086 | 0.030 |
Why?
|
| Urban Health | 2 | 2012 | 76 | 0.030 |
Why?
|
| Random Allocation | 1 | 1996 | 436 | 0.030 |
Why?
|
| Educational Status | 1 | 1996 | 273 | 0.030 |
Why?
|
| Glucose | 1 | 1999 | 880 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 1996 | 256 | 0.030 |
Why?
|
| Age Factors | 1 | 2001 | 2816 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1999 | 542 | 0.030 |
Why?
|
| Foot Diseases | 1 | 1993 | 24 | 0.030 |
Why?
|
| Protestantism | 1 | 2013 | 3 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 115 | 0.030 |
Why?
|
| Poverty | 2 | 2012 | 422 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2003 | 1176 | 0.030 |
Why?
|
| Sex Factors | 2 | 2000 | 1279 | 0.030 |
Why?
|
| Lisinopril | 1 | 2012 | 25 | 0.030 |
Why?
|
| Amlodipine | 1 | 2012 | 23 | 0.030 |
Why?
|
| Chlorthalidone | 1 | 2012 | 27 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2012 | 56 | 0.020 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2012 | 15 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1993 | 116 | 0.020 |
Why?
|
| College Admission Test | 1 | 1991 | 4 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2012 | 95 | 0.020 |
Why?
|
| Depression | 1 | 2000 | 1218 | 0.020 |
Why?
|
| Diastole | 1 | 2011 | 170 | 0.020 |
Why?
|
| Korea | 1 | 2011 | 35 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 235 | 0.020 |
Why?
|
| Attitude to Health | 1 | 1992 | 255 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 256 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 398 | 0.020 |
Why?
|
| Africa | 2 | 2001 | 133 | 0.020 |
Why?
|
| Phenotype | 1 | 1999 | 4256 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1690 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1992 | 386 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2012 | 672 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1284 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cotinine | 1 | 2007 | 23 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2007 | 35 | 0.020 |
Why?
|
| Group Processes | 1 | 2007 | 47 | 0.020 |
Why?
|
| Health Facility Environment | 1 | 2006 | 7 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2007 | 89 | 0.020 |
Why?
|
| Public Health Practice | 1 | 2006 | 21 | 0.020 |
Why?
|
| Focus Groups | 1 | 2007 | 198 | 0.020 |
Why?
|
| Sodium | 1 | 2007 | 295 | 0.020 |
Why?
|
| Triage | 1 | 2006 | 139 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 1010 | 0.010 |
Why?
|
| Radiology | 1 | 2006 | 106 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2557 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2006 | 256 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 12466 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2003 | 105 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 14007 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 996 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 19275 | 0.010 |
Why?
|
| Angiotensinogen | 1 | 2001 | 21 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2007 | 711 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2001 | 54 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1984 | 332 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 2044 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2001 | 313 | 0.010 |
Why?
|
| Students, Medical | 1 | 1984 | 357 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 284 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2000 | 122 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 2891 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1999 | 277 | 0.010 |
Why?
|
| Heart Failure | 1 | 2012 | 2283 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 1999 | 106 | 0.010 |
Why?
|
| Mandatory Reporting | 1 | 1999 | 16 | 0.010 |
Why?
|
| Lactic Acid | 1 | 1999 | 154 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1999 | 208 | 0.010 |
Why?
|
| Child | 1 | 2018 | 24367 | 0.010 |
Why?
|
| Mexican Americans | 1 | 1999 | 204 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 1323 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 1605 | 0.010 |
Why?
|
| Pediatrics | 1 | 2006 | 1160 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2000 | 1254 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 711 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2001 | 999 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1999 | 775 | 0.010 |
Why?
|
| Cost Savings | 1 | 1993 | 71 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6293 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1993 | 90 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 1993 | 140 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1993 | 202 | 0.010 |
Why?
|
| Health Education | 1 | 1993 | 220 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1996 | 2876 | 0.000 |
Why?
|